The U.S. Food and Drug Administration issued a safety notice on May 28, 2020 alerting patients and healthcare professionals about contaminated extended-release metformin drug products used to treat type 2 diabetes. The agency found independent samples of these drugs contained unacceptable levels of N-Nitrosodimethylamine (NDMA), a known carcinogen. The FDA warns that people taking these drugs are at a higher risk of developing serious illness including cancer. This same impurity was also the basis for a recent recalls for Zantac and Valsartan.  The agency has contacted five drug manufacturers that make extended-release metformin and asked for recalls. Apotex,  Amneal, Teva, Marksans and Lupin Pharmaceuticals have all recalled extended-release metformin drugs.

If you or someone you know has been prescribed extended-release metformin drugs and has been diagnosed with a serious illness, contact us. Our product liability attorneys can provide you with a free case evaluation and discuss your legal rights and options.